A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

Chronic infection with hepatitis C virus (HCV) may lead to liver failure and hepatocellular carcinoma. Current treatment for HCV includes high systemic doses of interferonα (IFNα), which is effective ...

This faster polymerase chain test (PCR) allows same-day diagnosis and prompt treatment for the people affected with liver disease. This expeditious assessment aims to prevent costly and ruinous ...

According to a new study presented at The Liver Meeting, combining universal screening for the hepatitis C virus (HCV) with reflex RNA PCR in pregnant women is more cost-effective than risk-based ...

GENT, Belgium--(BUSINESS WIRE)--Fujirebio Europe today announced the availability* of the INNO-LiPA HCV 2.0 Genotyping assay. The product, previously distributed by Siemens Healthcare Diagnostics Inc.

Less than 15% of patients with HCV infection have a spontaneous cure. Normalization of serum aminotransferases and disappearance of anti-HCV antibodies do not indicate clearance of the infection. In a ...

To develop the new rapid polymerase chain reaction (PCR) test for HCV, the scientists used the DASH® (Diagnostic Analyzer for Specific Hybridization)PCR platform, which was originally developed at ...

Protedyne have integrated their Radius™ bench top robotic system with Roche Diagnostics' LightCycler 480 Real-Time PCR System to create an automated high-throughput solution for real-time PCR assays.